Investigación
In addition to inventing technology to accurately diagnose cirrhosis, Mayo Clinic researchers developed the model for end-stage liver disease (MELD) score. The MELD scoring system is now used nationwide to assess people's disease progression and allocate organs for transplant.
Researchers in the Transplant Research Center are actively engaged in studying improved surgical procedures and developing new antirejection medicines, treatments and techniques to make transplants safer and available to more people. Mayo Clinic scientists, doctors and surgeons develop liver transplant insights and innovations that make transplants safer and available for more people. They are actively involved in conducting laboratory studies, clinical trials and other research on every aspect of conditions related to liver transplants.
Publications
See a list of publications about the MELD score by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.